Real World Chart Review
Showing 1 - 25 of >10,000
HER2 and LA/mUC: A Multi-country Chart Review Cohort Study
Not yet recruiting
- Urothelial Carcinoma
- (no location specified)
Jun 5, 2023
Called RegoFlex EU, to Learn More About Use of Stivarga at
Completed
- Metastatic Colorectal Cancer
- Retrospective patient chart review
-
Whippany, New JerseyMany locations
Jan 24, 2023
Nivolumab in Recurring Kidney Cancer Participants
Completed
- Kidney Cancer
- Renal Cancer
- Non-Interventional
-
Tokyo, JapanLocal Institution - 0001
Oct 19, 2022
Patients Admitted With Septic Shock in Intensive Care Unit
Recruiting
- Critical Illness
- +2 more
- Retrospective chart review
-
Al Ain, United Arab EmiratesTawam Hospital ICU
Feb 14, 2023
Afatinib Following Immunotherapy in Treatment of Metastatic,
Completed
- Non-squamous, Non-Small Cell Lung Cancer
- Afatinib
- other systemic therapy
-
Dublin, OhioCardinal Health
Jan 18, 2022
Effect of Fiasp® in Type 1 Diabetes Treatment
Completed
- Diabetes Mellitus, Type 1
-
Stockholm, SwedenNovo Nordisk Investigational Site
Apr 6, 2022
Patterns of Real-World Isavuconazole Use -Study of Mucormycosis
Recruiting
- Invasive Aspergillosis
- Mucormycosis
-
Barcelona, SpainFundació Clínic Per A La Recerca Biomèdica
Jun 14, 2021
Nivolumab in Participants That Have Head and Neck Cancer That
Completed
- Cancer of Head and Neck
- +2 more
-
Tokyo, JapanLocal Institution
Jan 27, 2022
InO - A Retrospective Study of UK Patients With Leukaemia
Completed
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Inotuzumab Ozogamicin
-
Bristol, United Kingdom
- +3 more
Jan 27, 2022
Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer
Completed
- Non-Small Cell Lung Cancer
-
Minato-ku, Tokyo, JapanLocal Institution
Jan 20, 2022
United States Using Electronic Medical Records to Assess
Completed
- Squamous Non-small Cell Lung Cancer
- Second line (2L) afatinib
- Second line chemotherapy
-
Dublin, OhioCardinal Health Specialty Solutions
Dec 22, 2021
Teenagers and Hereditary Angioedema Type I or Type II Who Use
Completed
- Hereditary Angioedema (HAE)
-
Graz, Austria
- +19 more
Jan 12, 2023
Describe Post-authorisation Early Clinical Experience of
Active, not recruiting
- Asthma
- No intervention
-
Chilly-Mazarin, FranceInvestigational Site Number :
Sep 26, 2023
Finland Treated With Tofacitinib for Treatment of Ulcerative
Completed
- Ulcerative Colitis
-
Helsinki, FinlandPfizer
Dec 15, 2022
Healthcare Resource Utilization in Adult Myelofibrosis Through
Recruiting
- Myelofibrosis
-
La Plata, Buenos Aires, Argentina
- +62 more
Feb 1, 2023
Non-functional Neuroendocrine Tumors of Pancreatic Body and Tail
Recruiting
- Non Functioning Pancreatic Endocrine Tumor
- Histopathological review, long-term prognosis and quality of life follow-up
-
Shanghai, Shanghai, ChinaDepartment of Pancreatic Surgery, Fudan University Shanghai Canc
Jun 8, 2023
POmalidomide Plus LoW Dose Dexa Efficacy in RRMM Patients Under
Completed
- Relapse/Refractory Multiple Myeloma
-
Patra, GreeceAg.Andreas General Hospital
May 10, 2021
Treataprost Added to Antibiotic Treatment in Chronic Prostatitis
Not yet recruiting
- Quality of Life
- +3 more
- TREATAPROST
-
Eskişehir, Turkey
- +3 more
Mar 23, 2022
Advanced Classical Hodgkin's Lymphoma in Brazil Treated With
Not yet recruiting
- Hodgkin Lymphoma
- No Intervention
-
Salvador, Bahia, Brazil
- +5 more
Oct 23, 2023
Among Advanced Renal Cell Carcinoma Receiving Systemic
Not yet recruiting
- Carcinoma, Renal Cell
- (no location specified)
Sep 6, 2022
SLE Patients Treated With Anifrolumab in Early Access Programs
Not yet recruiting
- Systemic Lupus Erythematosus
- None (Observational study)
- (no location specified)
Sep 13, 2023